Skip to content
HowShorted

Monopar Therapeutics short interest in 2026

In 2026, Monopar Therapeutics's disclosed short interest ran from 19.14% of shares outstanding on 15 Jan 2026 to 12.58% on 15 Sep 2026, a change of -6.56 percentage points. The year's high was 25.75% on 15 Apr 2026 and its low 12.58% on 15 Sep 2026, averaging 20.83% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 12.54 days on 15 Jun 2026. Full history: Monopar Therapeutics.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Monopar Therapeutics in 2026

2026 in figures

Start of year
19.14% (15 Jan 2026)
End of year
12.58% (15 Sep 2026)
Change
-6.56 pp
High
25.75% (15 Apr 2026)
Low
12.58% (15 Sep 2026)
Average
20.83%
Highest days to cover
12.54 (15 Jun 2026)
SEC filings marked
6

Every report in 2026

Monopar Therapeutics short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 202619.14%4.07
30 Jan 202620.28%4.26
13 Feb 202622.54%5.11
27 Feb 202623.80%10.83
13 Mar 202624.74%10.45
31 Mar 202625.17%7.9810-K filed, results (8-K)
15 Apr 202625.75%9.34
30 Apr 202624.96%10.60
15 May 202623.45%8.0510-Q filed, results (8-K)
29 May 202623.60%8.53
15 Jun 202623.28%12.54
30 Jun 202622.71%8.61
15 Jul 202620.33%5.94
31 Jul 202615.87%3.40
14 Aug 202613.22%3.4810-Q filed, results (8-K)
31 Aug 202612.70%4.54
15 Sep 202612.58%7.20

See also: Monopar Therapeutics's full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.